UY26303A1 - Composiciones farmacéuticas para administración oral y tópica - Google Patents

Composiciones farmacéuticas para administración oral y tópica

Info

Publication number
UY26303A1
UY26303A1 UY26303A UY26303A UY26303A1 UY 26303 A1 UY26303 A1 UY 26303A1 UY 26303 A UY26303 A UY 26303A UY 26303 A UY26303 A UY 26303A UY 26303 A1 UY26303 A1 UY 26303A1
Authority
UY
Uruguay
Prior art keywords
fatty acids
oral
topical administration
compounds selected
pharmaceutical compositions
Prior art date
Application number
UY26303A
Other languages
English (en)
Spanish (es)
Inventor
Tomas Andrysek Alexan Stuchlik
Ales Vrana
Vladimir Matha
Original Assignee
Ivax Cr A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY26303(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ivax Cr A S filed Critical Ivax Cr A S
Publication of UY26303A1 publication Critical patent/UY26303A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
UY26303A 1999-08-17 2000-08-17 Composiciones farmacéuticas para administración oral y tópica UY26303A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration

Publications (1)

Publication Number Publication Date
UY26303A1 true UY26303A1 (es) 2001-03-16

Family

ID=10859192

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26303A UY26303A1 (es) 1999-08-17 2000-08-17 Composiciones farmacéuticas para administración oral y tópica

Country Status (40)

Country Link
US (1) US20070190132A1 (https=)
EP (2) EP1334717B1 (https=)
JP (2) JP2003507343A (https=)
KR (2) KR100828748B1 (https=)
CN (2) CN1382061A (https=)
AR (2) AR025324A1 (https=)
AT (2) ATE402691T1 (https=)
AU (1) AU777740B2 (https=)
BR (1) BR0013385A (https=)
CA (2) CA2452118A1 (https=)
CO (1) CO5380014A1 (https=)
CY (1) CY1105318T1 (https=)
CZ (2) CZ296170B6 (https=)
DE (2) DE60018081T2 (https=)
DK (2) DK1210119T3 (https=)
EE (2) EE04954B1 (https=)
EG (1) EG23994A (https=)
ES (2) ES2311077T3 (https=)
GB (1) GB2355656B (https=)
HK (1) HK1049629A1 (https=)
HR (1) HRP20020154B1 (https=)
HU (1) HUP0203236A3 (https=)
IL (4) IL158108A0 (https=)
JO (1) JO2324B1 (https=)
MX (1) MXPA02001631A (https=)
NO (2) NO20020760L (https=)
NZ (1) NZ517271A (https=)
PE (1) PE20010636A1 (https=)
PL (1) PL192769B1 (https=)
PT (2) PT1210119E (https=)
RU (2) RU2279894C2 (https=)
SA (1) SA00210487B1 (https=)
SG (1) SG143019A1 (https=)
SI (1) SI1210119T1 (https=)
SK (2) SK286083B6 (https=)
TN (1) TNSN00173A1 (https=)
UA (2) UA72539C2 (https=)
UY (1) UY26303A1 (https=)
WO (1) WO2001012229A1 (https=)
ZA (2) ZA200308221B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7101576B2 (en) * 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムｑ１０を含有する水溶性組成物の製造方法
KR101061679B1 (ko) * 2002-12-04 2011-09-02 닛신 파마 가부시키가이샤 코엔자임 ｑ10 을 함유하는 수용성 조성물
CA2509365C (en) * 2002-12-09 2012-08-07 American Bioscience, Inc. Compositions and methods of delivery of pharmacological agents
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
WO2006043621A1 (ja) * 2004-10-20 2006-04-27 Kao Corporation 液体口腔用組成物
JP2008531591A (ja) * 2005-02-24 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド ドセタキセルおよびそれらの類似体のナノ粒子製剤
BRPI0921654A2 (pt) * 2008-11-28 2016-02-10 Advance Holdings Ltd formulação farmacêutica
WO2010102862A1 (en) * 2009-03-12 2010-09-16 Advance Holdings Limited Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
KR20170131641A (ko) 2015-03-27 2017-11-29 아치 퍼스널 케어 프로덕츠, 엘.피. 퍼스널 케어 제품용 점도 증강 조성물
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
TW202406566A (zh) * 2022-05-02 2024-02-16 日商中外製藥股份有限公司 包含用於與界面活性劑結合使用之胜肽化合物的組合物
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ283516B6 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
CA2283780A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
ATE265847T1 (de) * 1997-07-29 2004-05-15 Upjohn Co Selbstemulgierbare formulierung enthaltend lipophile verbindungen
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
JO2324B1 (en) 2005-09-12
RU2279894C2 (ru) 2006-07-20
ZA200308221B (en) 2004-09-29
RU2003133451A (ru) 2005-04-20
SA00210487B1 (ar) 2006-09-10
SK286083B6 (sk) 2008-03-05
EP1334717A3 (en) 2004-01-02
IL158108A0 (en) 2004-03-28
DK1210119T3 (da) 2005-06-20
GB2355656A (en) 2001-05-02
ES2311077T3 (es) 2009-02-01
EE04954B1 (et) 2008-02-15
UA75926C2 (en) 2006-06-15
CY1105318T1 (el) 2010-03-03
ES2237443T3 (es) 2005-08-01
CA2452118A1 (en) 2001-02-22
PE20010636A1 (es) 2001-06-02
GB2355656B (en) 2004-04-07
CA2380951A1 (en) 2001-02-22
CN1382061A (zh) 2002-11-27
NO20034778D0 (no) 2003-10-24
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
EP1334717A2 (en) 2003-08-13
KR20020059367A (ko) 2002-07-12
DE60322454D1 (de) 2008-09-11
ATE288766T1 (de) 2005-02-15
ZA200201315B (en) 2004-06-30
CO5380014A1 (es) 2004-03-31
JP2004238399A (ja) 2004-08-26
DE60018081D1 (de) 2005-03-17
IL148200A (en) 2007-12-03
IL148200A0 (en) 2002-09-12
HRP20020154A2 (en) 2003-12-31
BR0013385A (pt) 2002-05-07
PL353445A1 (en) 2003-11-17
NZ517271A (en) 2004-02-27
HRP20020154B1 (en) 2006-07-31
RU2279895C2 (ru) 2006-07-20
EP1210119B1 (en) 2005-02-09
KR100828748B1 (ko) 2008-05-09
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
ATE402691T1 (de) 2008-08-15
PT1334717E (pt) 2008-10-09
CN101406453A (zh) 2009-04-15
NO20020760L (no) 2002-04-16
EP1210119A1 (en) 2002-06-05
TNSN00173A1 (en) 2005-11-10
AU6461300A (en) 2001-03-13
US20070190132A1 (en) 2007-08-16
HUP0203236A3 (en) 2004-06-28
DE60018081T2 (de) 2006-01-05
WO2001012229A1 (en) 2001-02-22
SK2482002A3 (en) 2002-12-03
CZ296170B6 (cs) 2006-01-11
AR025324A1 (es) 2002-11-20
AU777740B2 (en) 2004-10-28
UA72539C2 (en) 2005-03-15
HK1049629A1 (zh) 2003-05-23
GB9919288D0 (en) 1999-10-20
DK1334717T3 (da) 2008-11-24
CZ2002575A3 (cs) 2003-05-14
SI1210119T1 (en) 2005-06-30
EG23994A (en) 2008-03-10
MXPA02001631A (es) 2003-07-14
PT1210119E (pt) 2005-05-31
KR20050095651A (ko) 2005-09-29
EE200300371A (et) 2003-10-15
IL158108A (en) 2010-04-15
HUP0203236A2 (hu) 2003-01-28
PL192769B1 (pl) 2006-12-29
SG143019A1 (en) 2008-06-27
EE04955B1 (et) 2008-02-15
EP1334717B1 (en) 2008-07-30
NO20020760D0 (no) 2002-02-15
AR043106A2 (es) 2005-07-20
CA2380951C (en) 2010-03-23
JP2003507343A (ja) 2003-02-25

Similar Documents

Publication Publication Date Title
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
DK0904064T3 (da) Orale farmaceutiske præparater indeholdende kønshormoner
ATE279209T1 (de) Injizierbare pharmazeutische zusammensetzung zur systemischen verabreichung pharmakologisch aktiver wirkstoffe enthaltend mittelkettige triglyceride
DK1152755T3 (da) Essentielle fedtsyrer til forebyggelse af cardiovaskulære tilfælde
CO5140102A1 (es) Formulacion farmaceutica en forma de pasta semisolida estabilizada para administracion oral que comprende omeprazol, de dos a cuatro agentes basificantes, un agente espesante y un vehiculo aceitoso hidrofobico
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
IL142535A0 (en) Pharmaceutical compositions for the treatment of inflammation
ES2195798T1 (es) Formulacion para mujeres menopausicas.
DK1073415T3 (da) Gelerbare farmaceutiske sammensætninger
WO2003013497A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
UA102477C2 (en) Capsule composition
MY127430A (en) Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
EE05231B1 (et) Tramadoolvesinikkloriidi sisaldav toimeainet reguleeritult vabastav ravimkoostis ja meetod selle valmistamiseks
KR940003551A (ko) W-3다불포화산 에스테르를 함유한 신규 약제 조성물 및 이들을 병변 국소 치료용으로 사용하는 방법
DK0938339T3 (da) Formuleringer til topisk anvendelse indeholdende vitamin-E acetat
UY28008A1 (es) Composiciones farmacéuticas para administración oral y tópica
ATE228556T1 (de) An omega-3 ungesättigten fettsäuren angereicherte wachsester, ihre herstellung und verwendung
CO4940404A1 (es) Composiciones farmaceuticas
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
WO2002049642A3 (en) Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20110726